ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,778.00
      -0.69%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      101,951.31
      -0.45%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Italy
      5. BIT

      6. Philogen Spa (PHIL) Quote

      Philogen Spa

      Philogen Spa (PHIL)

      Pacific Horizon Investment Trust PLC
      Pacific Horizon Investment Trust PLC
      Pacific Horizon Investment Trust PLC
      PHI Group Inc (PK)
      17.50
      -0.25
      (-1.41%)
      Closed February 01 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      17.50
      Bid
      17.05
      Ask
      17.80
      Volume
      16,543
      17.25 Day's Range 18.00
      16.30 52 Week Range 21.90
      Market Cap
      706.958M
      Previous Close
      17.75
      Open
      17.95
      Last Trade
      82
      @
      17.5
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      5,462
      Shares Outstanding
      40,397,605
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      25.12M
      Net Profit
      -6.16M

      About Philogen Spa

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.philogen.com
      Headquarters
      Siena, Siena, Ita
      Founded
      -
      Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 17.75 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

      Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 717.06 € million.

      Ask ADVFN Intelligence (AI)

      PHIL Latest News

      More News

      Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

      Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

      February 20 2024
      GlobeNewswire Inc.

      Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

      Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

      December 05 2023
      GlobeNewswire Inc.

      Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

      Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

      December 04 2023
      GlobeNewswire Inc.

      Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

      Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

      October 16 2023
      GlobeNewswire Inc.

      Philogen Announces Clinical Trial Collaboration with MSD

      Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

      June 01 2023
      GlobeNewswire Inc.

      Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

      Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

      May 30 2023
      GlobeNewswire Inc.

      Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

      Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

      May 25 2023
      GlobeNewswire Inc.

      Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

      Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

      March 28 2023
      GlobeNewswire Inc.

      Philogen Provides Corporate Update

      Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

      December 01 2022
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.65-3.5812672176318.1518.617.25701517.91518417DE
      4-1.6-8.3769633507919.119.217.25465318.33897468DE
      12-2.45-12.280701754419.9520.517.25546218.95789148DE
      26-3.2-15.458937198120.721.917.25644119.79939277DE
      520.52.941176470591721.916.3839719.14497544DE
      1563.0421.023513139714.4621.913852516.9618757DE
      2600.52.941176470591721.912.61198316.03934691DE

      PHIL - Frequently Asked Questions (FAQ)

      What is the current Philogen share price?
      The current share price of Philogen is 17.50 €
      How many Philogen shares are in issue?
      Philogen has 40,397,605 shares in issue
      What is the market cap of Philogen?
      The market capitalisation of Philogen is EUR 717.06M
      What is the 1 year trading range for Philogen share price?
      Philogen has traded in the range of 16.30 € to 21.90 € during the past year
      What is the reporting currency for Philogen?
      Philogen reports financial results in EUR
      What is the latest annual turnover for Philogen?
      The latest annual turnover of Philogen is EUR 25.12M
      What is the latest annual profit for Philogen?
      The latest annual profit of Philogen is EUR -6.16M
      What is the registered address of Philogen?
      The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100
      What is the Philogen website address?
      The website address for Philogen is www.philogen.com
      Which industry sector does Philogen operate in?
      Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WABTGAlfio Bardolla Training Group Spa
      0.15 €
      (25.00%)
      		1.35k
      EPHEPH SpA
      0.021 €
      (23.53%)
      		144.59k
      NTWNetweek SpA
      0.069 €
      (21.05%)
      		6.56M
      1SPCEVirgin Galactic Holdings Inc
      5.30 €
      (15.22%)
      		600
      MPTImpianti SpA
      0.276 €
      (15.00%)
      		160.5k
      WERFOLaboratorio Farmaceutico Erfo SPA
      0.0212 €
      (-29.33%)
      		5.56k
      OSAOSAI Automation System SpA
      0.304 €
      (-18.93%)
      		449.42k
      1WBAWalgreens Boots Alliance Inc
      9.466 €
      (-13.32%)
      		516
      SOGESASoges Group AA
      0.0098 €
      (-10.91%)
      		3.9k
      WS3D25Solid World Group spa
      0.182 €
      (-9.00%)
      		67.8k
      TITTelecom Italia SpA
      0.2655 €
      (-0.45%)
      		82.64M
      SPMSaipem Spa
      2.365 €
      (0.72%)
      		22.21M
      BMPSBanca Monte Dei Paschi Di Siena Spa
      6.198 €
      (-0.48%)
      		20.74M
      ISPIntesa Sanpaolo Spa
      4.1935 €
      (-0.57%)
      		18.17M
      TITRTelecom Italia
      0.3079 €
      (-0.52%)
      		15.89M

      Discussion

      View Full Feed
      Kam8 Kam8 14 minutes ago
      LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
      NWBO
      manibiotech manibiotech 14 minutes ago
      Agree
      Usual few will pump this anyway 
      NWBO
      manibiotech manibiotech 15 minutes ago
      lol 
      The ceiling has already been put at 40M shares
      So dream on
      NWBO
      Deportes Deportes 17 minutes ago
      Gfy is that better?
      ENZC
      Hicham007 Hicham007 17 minutes ago
      Painful but nothing new...

      I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

      I am ready finan
      IOVA
      jammy32 jammy32 18 minutes ago
      As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
      API
      rosemountbomber rosemountbomber 18 minutes ago
      Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
      API
      BlazingStocks BlazingStocks 19 minutes ago
      $ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
      ILLR
      barnstormer barnstormer 19 minutes ago
      OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

      40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
      40,000,000 shares / 700,104 = 57.14 years
      NWBO
      BlazingStocks BlazingStocks 20 minutes ago
      Thank you for sharing this! 
      ILLR
      VMLG17 VMLG17 20 minutes ago
      And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
      NWBO
      Macod Macod 20 minutes ago
      CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

      O/S 526,142,269
      Restricted 297,633,160
      Unrestricted 228,509,109

      Increase of 7,6
      MRGE
      mascale mascale 20 minutes ago
      Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
      HIRU
      stealofadeal stealofadeal 21 minutes ago
      $ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
      BLTHD
      nowwhat2 nowwhat2 21 minutes ago
      scoop um up right at black swan.
      XRPUSD
      loophole lawyer loophole lawyer 22 minutes ago
      The 3 most important letters for GTCH…..P,C,T……Checkmate
      GTCH
      Preciouslife1 Preciouslife1 22 minutes ago
      https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
      jxyzobrien jxyzobrien 23 minutes ago
      hope you are well
      sounds like your company is doing great
      say hi when you can
      flipper44 flipper44 23 minutes ago
      The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
      NWBO
      x993231 x993231 25 minutes ago
      He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

      X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
      LWLG
      havnagoodtime havnagoodtime 25 minutes ago
      So, what is the short interest and the FTD report on DPLS? Thanks in advance.
      DPLS
      MartinLutherKing MartinLutherKing 26 minutes ago
      E Pluribus Unum brothers The one and only
      FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
      3 June 2024
      TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
      RNAZ
      gladeshawk gladeshawk 26 minutes ago
      AIRI>>>NEWS. Not a penny play but worth a look. HAWK

      https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
      AIRI
      MartinLutherKing MartinLutherKing 26 minutes ago
      E Pluribus Unum brothers The one and only
      FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
      3 June 2024
      TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
      RNAZ
      vein vein 26 minutes ago
      Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
      CKPT

      Your Recent History

      BIT
      PHIL
      Philogen
      NASDAQ
      ZKID
      Zkid Network
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads